Robert’s interests are in the application of new developments in molecular medicine to improve diagnosis and treatment of common illnesses in the community. He is establishing a programme of research using novel genetic diagnostic tests to tailor drug therapy more closely to the metabolic profile of individual patients. In the future this ‘personalised medicine’ may result in more effective treatments with fewer side effects. The initial focus will be on treatment for tobacco dependence. A randomised controlled trial is planned in London, together with larger scale implementation studies in Glasgow and Greater Clyde.